The
Centers for Disease Control and Prevention’s
Immunization Works Monthly Update is
provided to national health care provider
and consumer groups for distribution
to their members and constituencies.
The immunization information provided
is non-proprietary and is encouraged
to be widely disseminated and shared.
|
ACIP
releases the 2004 Recommendations
for the Prevention and Control
of Influenza |
CDC
released the 2004 recommendations for
the prevention and control of influenza
April 30, 2004 in the MMWR. The recommendations
from ACIP will be in effect for the 2004-2005
influenza season.
The
2004 recommendations include four principal
changes or updates:
- ACIP
recommends that healthy children aged
6-23 months, and close contacts of
children aged 0-23 months, be vaccinated
against influenza (see Target Groups
for Vaccination).
- Inactivated
vaccine is preferred over live, attenuated
influenza vaccine (LAIV) for vaccinating
household members, health-care workers,
and others who have close contact with
severely immunosuppressed persons during
periods when such persons require care
in a protected environment. If a health-care
worker receives LAIV, the health-care
worker should refrain from contact
with severely immunosuppressed patients
for 7 days after vaccine receipt. No
preference exists for inactivated vaccine
use by health-care workers or other
persons who have close contact with
persons with lesser degrees of immunosuppression
(see Live Attenuated Influenza Vaccine
Recommendations/Close Contacts of Persons
at High Risk for Complications from
Influenza).
- Severely
immunosuppressed persons should not
administer LAIV. However, other persons
at high risk for influenza complications
may administer LAIV (see Personnel
Who May Administer LAIV).
- The
2004-05 trivalent vaccine virus strains
are A/Fujian/411/2002 (H3N2)-like,
A/New Caledonia/20/99 (H1N1)-like,
and B/Shanghai/361/2002-like antigens.
For the A/Fujian/411/2002 (H3N2)-like
antigen, manufacturers may use the
antigenically equivalent A/Wyoming/3/2003
[H3N2] virus, and for the B/Shanghai/361/2002-like
antigen, manufacturers may use the
antigenically equivalent B/Jilin/20/2003
virus or B/Jiangsu/10/2003 virus (see
Influenza Vaccine Composition).
CDC
and other agencies will assess the vaccine
supply throughout the manufacturing period
and will make recommendations in the
summer preceding the 2004--05 influenza
season regarding the need for tiered
timing of vaccination of different risk
groups. The full text of this release
can be found at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr53e430a1.htm.
Other information regarding influenza
can be found at http://www.cdc.gov/flu.
 Top
The
38th National Immunization Conference:
This year’s 38th National Immunization
Conference (NIC) was held May 11- 14,
2004 at the Gaylord Opryland Hotel in
Nashville, TN. Over 1400 attendees participated
in eight plenary sessions, 102 workshops,
two Immunization Q &A sessions, and
various fitness events. All sessions
covered key immunization topics including
adult immunization, vaccine safety, community
and partnerships, cultural diversity,
immunization registries, and barriers
to immunization, just to name a few.
Slides, handouts, and audio/video files
will be available via the conference
program system soon. Please check http://www.cdc.gov/nip/NIC
for updates and information on CE credits.
2004
National Influenza Vaccine Summit:
The National Influenza Vaccine Summit
sponsored by CDC and the American Medical
Association (AMA) was held on April 13-14,
2004 at the Crowne Plaza Ravinia Hotel
in Atlanta, GA.
The
National Influenza Summit is now acknowledged
as an informal partnership of stakeholders
available to advise on and respond to
issues of influenza vaccination all year
round. Attendees participate by invitation
only. Additionally, throughout the year,
the Summit participants continue to collaborate
to lend their efforts to address barriers
that may reduce influenza vaccinations.
These range from addressing payment problems,
to communicating nationally on the benefits
of influenza vaccination, and to creating
tools to facilitate the provision of
vaccine.
Nine
working groups currently exist within
the Summit. Additionally, the Summit
stands ready to add new working groups
in response to new issues that may arise
for the 2004-2005 influenza season. For
a list of working groups and speaker
presentations, please visit http://www.ama-assn.org/ama/pub/article/1826-8377.html#summary.
Top
| Meetings,
Conferences, and Resources |
Coming
Soon Fifth Immunization Registry
Conference:
The 5th Immunization Registry Conference
will be held October 18–20, 2004,
at the Crowne Plaza Ravinia Hotel in
Atlanta, Georgia. Please visit our web
page at www.cdc.gov/nip/registry/irc
for more information as it becomes available.
The abstract submission system and the
online conference registration system
will be available in June.
| Sixth
National Conference on Immunization
Coalitions: |
 |
The
Sixth National Conference on Immunization
Coalitions is scheduled for September
20-22, 2004 at the Sheraton Norfolk
Waterside Hotel in Norfolk, Virginia.
|
This
year’s conference theme,
Chart Your Coalition’s Course
for Norfolk, describes the goal
of the meeting. The conference
provides training on how to create,
lead and sustain effective local
or state coalitions and partnerships
that address childhood, adolescent
and adult immunizations. Specifically,
the conference addresses coalitions
as agents of social change, the
elements of a successful coalition
and ethnic diversity in coalitions.
For
conference brochure and registration
information, please visit our website
at www.cme.hsc.usf.edu/coph/immcoal,
or call 813-974-6695 or toll-free
888-USF-COPH (Press "2"
for Continuing Education). |
Top
| Vaccines:
Preventing Disease and Protecting
Health: |
 |
Vaccines:
Preventing Disease and Protecting
Health celebrates the various ways
vaccines have played a role in improving
the health of the world’s populations.
This book’s chapters discuss
progress made through vaccines used
in most of the world’s immunization
programs, describe the status of
introduction of the newest vaccines
currently available to immunization
programs, review |
progress in the development of
vaccines against some bacterial
and viral diseases that are responsible
for much of mortality due to diarrheal
and acute respiratory illnesses,
as well as the quest for vaccines
against HIV/AIDS, malaria, and
dengue. A section addresses technological
aspects of vaccine development,
such as new concepts, including
DNA vaccine technology, and new
adjuvants and delivery systems.
Diseases that may be used for bioterrrorism,
such as smallpox and anthrax, also
are discussed. The roster of authors
reads like a “Who’s
Who” in public health and
in vaccine development and use:
Dr. Anthony Fauci, Dr. Donald Henderson,
Peter Hotez, Dr. Ciro de Quadros,
among other important authors.
2004,
412 pp. ISBN 92 75 11596 6 US$
62.00/46.00 in Latin America and
the Caribbean. Order Code: SP 596.
Send your order to: PAHO Sales
and Distribution Center, Fax: 301-206-9789;
E-mail: paho@pmds.com; http://publications.paho.org.
|
National
Minority Organizations Immunization Projects:
CDC
has made available funding to assist
national minority organizations with
the promotion and improvement of childhood,
adolescent, and adult immunization coverage
levels among racial and ethnic minorities.
LOIs are due May 24, 2004, but are not
required. The application deadline is
June 21, 2004 and expected funding is
in August 2004. For a copy of the announcement,
visit www.cdc.gov/od/pgo/funding/04051.htm.
Top
Free
CMEs Available Related to the Vaccine
Adverse Event Reporting System (VAERS):
Health
care providers may access the “Vaccine
Safety Post-Marketing Surveillance: The
Vaccine Adverse Event Reporting System”
with free CMEs through September 19,
2004. To access the CME article visit
www.cdc.gov/nip/vacsafe/VAERS/CME-post-mktg-surv.htm.
Additional information related to VAERS
is available at http://vaers.hhs.gov.
Job
Openings within the National Immunization
Program:
NIP
is committed to recruiting and hiring
qualified candidates for a wide range
of positions. Researchers, Medical Officers
and Epidemiologists as well as other
specialties are often needed to fill
positions within NIP. We encourage all
interested parties to apply for these
jobs. For a current listing of positions
available at NIP, please visit www.cdc.gov/hrmo/hrmo.htm.
Once at the site, conduct a search for
“National Immunization Program.”
|
